Table 4.
Use of supportive care measures as initial AA treatment by disease severity
| Supportive care measure | SAA (n = 209) | VSAA (n = 83) | TH-NSAA(n = 48) | Total (n = 340) |
|---|---|---|---|---|
| Any supportive care | 204 (97.6) | 83 (100) | 38 (79.1) | 325 (95.6) |
| Blood transfusion | 199 (97.5) | 83 (100) | 36 (94.7) | 318 (97.8) |
| Hematopoietic growth factors | 122 (59.8) | 57 (68.7) | 10 (26.3) | 189 (58.2) |
| Protective isolation | 97 (47.5) | 51 (61.4) | 4 (10.5) | 152 (46.8) |
| Antibiotics | 123 (60.3) | 71 (85.5) | 13 (34.2) | 207 (63.7) |
| Iron chelation | 0 | 1 (1.2) | 0 | 1 (0.3) |
| Other | 7 (3.4) | 0 | 2 (5.3) | 9 (2.8) |
Data are presented asn (%). Patients may have received more than 1 type of supportive care measure. AA, anaplastic anemia; SAA, severe AA; VSAA, very severe AA; TD-NSAA, transfusion-dependent non-severe AA.